Precise Biopharma Gets CDSCO Panel Nod To Conduct Phase III Trial of Semaglutide Injection Susmita Roy12 Aug 2025 12:47 PM ISTNew Delhi: Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Tirzepatide superior to Semaglutide- SURMOUNT-5 Trial Results Deeksha Bhandari11 Aug 2025 12:54 PM IST In SURMOUNT-5 Treatment with tirzepatide MTD (10 or 15 mg) was superior to semaglutide MTD (1.7 or 2.4 mg) with respect to reduction in...
Indian pharma market registers 7.9 percent growth in July: Report MD Bureau9 Aug 2025 3:30 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) registered a growth of 7.9 percent in July 2025, and cardiac and anti-diabetes therapy segments have...
CDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study Susmita Roy9 Aug 2025 12:18 PM ISTNew Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central...
Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report Farhat Nasim29 July 2025 10:09 PM ISTNew Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...
Dr Reddy's Labs plans to roll out cheaper Wegovy copycat across 87 countries in 2026: CEO Ruchika Sharma25 July 2025 4:30 PM ISTHyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an affordable copycat version...
Once-Weekly Semaglutide-Insulin Combo Matches Daily Basal-Bolus in Type 2 Diabetes Control: Study Dr Riya Dave25 July 2025 9:30 AM ISTAccording to a Phase 3 trial published in The Lancet Diabetes & Endocrinology, a once-weekly combination of semaglutide and insulin icodec was...
Consuming more protein may protect patients taking anti-obesity drug from muscle loss: Study Dr. Kamal Kant Kohli24 July 2025 8:30 PM ISTWomen and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent...
Anti-obesity medications associated with weight rebound post-treatment,suggests study Dr. Kamal Kant Kohli23 July 2025 9:00 AM ISTPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis...
Weight Returns for Many After Stopping Anti-Obesity Drugs: Meta-Analysis Dr. Bhumika Maikhuri23 July 2025 8:00 AM ISTPatients who take anti-obesity medications to aid in weight loss may experience significant weight regain after stopping the drugs, according to a new...
Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study Medha Baranwal19 July 2025 9:15 AM ISTTaiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and...
GLP-1 RAs Lower Risk of Liver Damage and Death in Alcohol Use, reveals research Dr Riya Dave14 July 2025 9:15 AM ISTResearchers have determined in a new study that the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) lower the risk of alcohol-related liver...
